To determine whether NPY may be involved in human hepatic diseases with fibrosis, Dai and colleagues measured the amount of NPY in the serum of healthy volunteers and patients diagnosed with fibrotic liver diseases, such as liver cirrhosis and hepatocellular carcinoma. The gene discussed is NPY; the disease is cirrhosis of liver.